CIC missense variants contribute to susceptibility for spina bifida. Issue 12 (12th September 2022)

• Record Type: Journal Article
• Authors: Han, Xiao; Cao, Xuanye; Aguiar‐Pulido, Vanessa; Yang, Wei; Karki, Menuka; Ramirez, Paula Andrea Pimienta; Cabrera, Robert M.; Lin, Ying Linda; Wlodarczyk, Bogdan J.; Shaw, Gary M.; Ross, M. Elizabeth; Zhang, Cuilian; Finnell, Richard H.; Lei, Yunping
• Is Part Of: Human mutation. Volume 43:Issue 12(2022)
• Page Start: 2021
• Page End: 2032
• Publication Date: 2022-09-12
• Subjects: CIC -- FOLR1 -- NTDs -- PCP signaling pathway; Human chromosome abnormalities -- Periodicals; Mutation (Biology) -- Periodicals; 616.04205
• DOI: 10.1002/humu.24460
• Languages: English
• ISSNs: 1059-7794

Abstract

Abstract: Neural tube defects (NTDs) are congenital malformations resulting from abnormal embryonic development of the brain, spine, or spinal column. The genetic etiology of human NTDs remains poorly understood despite intensive investigation. CIC, homolog of the Capicua transcription repressor, has been reported to interact with ataxin‐1 (ATXN1) and participate in the pathogenesis of spinocerebellar ataxia type 1. Our previous study demonstrated that CIC loss of function (LoF) variants contributed to the cerebral folate deficiency syndrome by downregulating folate receptor 1 (FOLR1) expression. Given the importance of folate transport in neural tube formation, we hypothesized that CIC variants could contribute to increased risk for NTDs by depressing embryonic folate concentrations. In this study, we examined CIC variants from whole‐genome sequencing (WGS) data of 140 isolated spina bifida cases and identified eight missense variants of CIC gene. We tested the pathogenicity of the observed variants through multiple in vitro experiments. We determined that CIC variants decreased the FOLR1 protein level and planar cell polarity (PCP) pathway signaling in a human cell line (HeLa). In a murine cell line (NIH3T3), CIC loss of function variants downregulated PCP signaling. Taken together, this study provides evidence supporting CIC as a risk gene for human NTD.